199 related articles for article (PubMed ID: 19213826)
1. Sodium MR imaging detection of mild Alzheimer disease: preliminary study.
Mellon EA; Pilkinton DT; Clark CM; Elliott MA; Witschey WR; Borthakur A; Reddy R
AJNR Am J Neuroradiol; 2009 May; 30(5):978-84. PubMed ID: 19213826
[TBL] [Abstract][Full Text] [Related]
2. 3T sodium MR imaging in Alzheimer's disease shows stage-dependent sodium increase influenced by age and local brain volume.
Haeger A; Boumezbeur F; Bottlaender M; Rabrait-Lerman C; Lagarde J; Mirzazade S; Krahe J; Hohenfeld C; Sarazin M; Schulz JB; Romanzetti S; Reetz K
Neuroimage Clin; 2022; 36():103274. PubMed ID: 36451374
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.
Kantarci K; Knopman DS; Dickson DW; Parisi JE; Whitwell JL; Weigand SD; Josephs KA; Boeve BF; Petersen RC; Jack CR
Radiology; 2008 Jul; 248(1):210-20. PubMed ID: 18566174
[TBL] [Abstract][Full Text] [Related]
4. Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.
Bartha R; Megyesi JF; Watling CJ
AJNR Am J Neuroradiol; 2008 Mar; 29(3):464-70. PubMed ID: 18238848
[TBL] [Abstract][Full Text] [Related]
5. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
[No Abstract] [Full Text] [Related]
6. Tissue sodium concentration in myocardial infarction in humans: a quantitative 23Na MR imaging study.
Ouwerkerk R; Bottomley PA; Solaiyappan M; Spooner AE; Tomaselli GF; Wu KC; Weiss RG
Radiology; 2008 Jul; 248(1):88-96. PubMed ID: 18566171
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Sodium (
Mohamed SA; Herrmann K; Adlung A; Paschke N; Hausner L; FrÖlich L; Schad L; Groden C; Kerl HU
In Vivo; 2021; 35(1):429-435. PubMed ID: 33402493
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
MacKay S; Ezekiel F; Di Sclafani V; Meyerhoff DJ; Gerson J; Norman D; Fein G; Weiner MW
Radiology; 1996 Feb; 198(2):537-45. PubMed ID: 8596863
[TBL] [Abstract][Full Text] [Related]
9. Increased brain tissue sodium concentration in Huntington's Disease - a sodium imaging study at 4 T.
Reetz K; Romanzetti S; Dogan I; Saß C; Werner CJ; Schiefer J; Schulz JB; Shah NJ
Neuroimage; 2012 Oct; 63(1):517-24. PubMed ID: 22796981
[TBL] [Abstract][Full Text] [Related]
10. Comparing 3T and 1.5T MRI for mapping hippocampal atrophy in the Alzheimer's Disease Neuroimaging Initiative.
Chow N; Hwang KS; Hurtz S; Green AE; Somme JH; Thompson PM; Elashoff DA; Jack CR; Weiner M; Apostolova LG;
AJNR Am J Neuroradiol; 2015 Apr; 36(4):653-60. PubMed ID: 25614473
[TBL] [Abstract][Full Text] [Related]
11. Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.
Tiepolt S; Rullmann M; Jochimsen TH; Gertz HJ; Schroeter ML; Patt M; Sabri O; Barthel H
Eur J Radiol; 2020 Oct; 131():109243. PubMed ID: 32916411
[TBL] [Abstract][Full Text] [Related]
12. Linear measures of atrophy in mild Alzheimer disease.
Frisoni GB; Beltramello A; Weiss C; Geroldi C; Bianchetti A; Trabucchi M
AJNR Am J Neuroradiol; 1996 May; 17(5):913-23. PubMed ID: 8733967
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging in Alzheimer disease: an evidence-based review.
Kantarci K; Jack CR
Neuroimaging Clin N Am; 2003 May; 13(2):197-209. PubMed ID: 13677801
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.
Ishii K; Sasaki H; Kono AK; Miyamoto N; Fukuda T; Mori E
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):959-63. PubMed ID: 15800784
[TBL] [Abstract][Full Text] [Related]
16. Initial experience in using continuous arterial spin-labeled MR imaging for early detection of Alzheimer disease.
Raji CA; Lee C; Lopez OL; Tsay J; Boardman JF; Schwartz ED; Bartynski WS; Hefzy HM; Gach HM; Dai W; Becker JT
AJNR Am J Neuroradiol; 2010 May; 31(5):847-55. PubMed ID: 20075093
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.
Fellgiebel A; Wille P; Müller MJ; Winterer G; Scheurich A; Vucurevic G; Schmidt LG; Stoeter P
Dement Geriatr Cogn Disord; 2004; 18(1):101-8. PubMed ID: 15087585
[TBL] [Abstract][Full Text] [Related]
18. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
[TBL] [Abstract][Full Text] [Related]
19. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
[TBL] [Abstract][Full Text] [Related]
20. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease.
Chantal S; Braun CM; Bouchard RW; Labelle M; Boulanger Y
Brain Res; 2004 Apr; 1003(1-2):26-35. PubMed ID: 15019560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
